Regeneus Share Price and Company Fundamentals



Price
$0.052
Change
-0.001 (-1.887%)
52 week
0.041 - 0.094

Last traded: Today at 4:16 AM

Regeneus Ltd, a clinical-stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, and neuropathic pain and dermatology diseases in Australia. Its lead platform technology includes Progenza, a cryopreserved multi-synergistic therapy for the treatment of osteoarthritis and neuropathic pain. The company also develops Sygenus for the treatment of skin wound healing. Regeneus Ltd was incorporated in 2007 and is headquartered in Paddington, Australia.

Key Metrics

PE ratio

-

PB ratio

6.79

Dividend yield

0.00%

Beta

-0.13

Market cap

-

Enterprise value

-

Company profile

Primary activitiesRegenerative medicine.
Industry / SectorBiotechnology / Healthcare
Websitehttps://regeneus.com.au
Mailing address2 Paddington Street Paddington NSW 2021 Australia
Phone / Fax61 1300 995 098 / 61 2 9499 8020
Share registryLINK MARKET SERVICES LIMITED

Dividends

More: Regeneus Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Regeneus paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.RGS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

RGS's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on Regeneus.

NameTitleAgeTotal Pay
Mr. Karolis RosickasChief Exec. Officer326.33k
Prof. Graham Vesey Ph.D.Chief Scientific Officer & Exec. Director56173.43k
Dr. Charlotte Morgan Ph.D.Head of R&D
Ling Leung HangCompany Sec.

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-546.77%

Return on assets

-63.49%

Return on equity

-130.79%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Regeneus is and its enterprise value is .

Companies similar to Regeneus (RGS)

Regeneus (ASX:RGS) Frequently Asked Questions

1. What is Regeneus's Stock Symbol?

Regeneus trades on ASX under the ticker symbol "RGS".

2. What is Regeneus's stock price today?

One share of RGS stock can currently be purchased for approximately $0.052.

3. How can I contact Regeneus?

Regeneus's mailing address is 2 Paddington Street Paddington NSW 2021 Australia. The company can be reached via phone at 61 1300 995 098.

4. What is Regeneus's official website?

The official website of Regeneus is https://regeneus.com.au.

5. Which share registry manages Regeneus's stock?

Regeneus's stock is managed by LINK MARKET SERVICES LIMITED.